Skip to content
value.today

EpiBiologics, Inc.

🇺🇸 San Mateo, California, USABiotechnologyFounded 2021
Total raised
$73 M
1 round on record
Latest round
$73 M
Mar 2022
First round on record
Mar 2022
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of EpiBiologics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2022$73 MNo. 1$50 to $250 million

EpiBiologics, Inc.: Raise no. 1, Mar 2022

Investors in this round

15 investors had bought by the notice of Apr 25, 2024: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$73 M of $73 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ann Lee-Karlon · Executive Officer, Director
  • Mitchell Mutz · Executive Officer, Director
  • Alexandra Cantley · Director
  • James Wells · Director
  • Jason Coloma · Director
  • Samuel Bjork · Director
  • Seiji Miyahara · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Includes $376,150 value of canceled convertible promissory notes.”

Signed by Ann Lee-Karlon, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Apr 25, 2024. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • EpiBiologics, Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2024).

    SEC Form D · Apr 2024

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Apr 2024

That is all the official record says: EpiBiologics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of EpiBiologics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 15 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by EpiBiologics, Inc.
NameRoleNamed in
Ann Lee-KarlonExecutive officerApr 2024
Mitchell MutzExecutive officerApr 2024
Craig LichtensteinExecutive officerApr 2023
Rami HannoushExecutive officerApr 2023
Alexandra CantleyDirectorApr 2024
Ann Lee-KarlonDirectorApr 2024
James WellsDirectorApr 2024
Jason ColomaDirectorApr 2024
Mitchell MutzDirectorApr 2024
Samuel BjorkDirectorApr 2024
Seiji MiyaharaDirectorApr 2024
Michael KavanaughDirectorApr 2023
Rami HannoushDirectorApr 2023